Terms: = Pancreatic cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
249 results:
1. A Comparison of Spatial and Phenotypic Immune Profiles of pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Enzler T; Shi J; McGue J; Griffith BD; Sun L; Sahai V; Nathan H; Frankel TL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474199
[TBL] [Abstract] [Full Text] [Related]
2. [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer].
Xu D; Tu M; Zhang K; Wu PF; Lyu N; Wang QQ; Yin J; Wu Y; Lu ZP; Chen JM; Xi CH; Wei JS; Guo F; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2024 Feb; 62(2):147-154. PubMed ID: 38310383
[No Abstract] [Full Text] [Related]
3. [Tolerability and Outcome of Neoadjuvant GS Therapy for Resectable pancreatic cancer].
Yamashita M; Shimizu J; Sato Y; Noma T; Hagihara K; Yanagimoto Y; Suzuki Y; Ikenaga M; Kawase T; Imamura H; Akagi K; Iwasawa S; Tomita N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1411-1413. PubMed ID: 38303291
[TBL] [Abstract] [Full Text] [Related]
4. Association between Pancreatoblastoma and Familial Adenomatous Polyposis: Review of the Literature with an Additional Case.
Remo A; Negro S; Bao RQ; d'Angelo E; Alaggio R; Crivellari G; Mammi I; Intini R; Bergamo F; Fassan M; Agostini M; Vitellaro M; Pucciarelli S; Urso EDL
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254934
[TBL] [Abstract] [Full Text] [Related]
5. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine treatment in Patients With Advanced pancreatic cancer.
Iede K; Yamada T; Ishida T; Tsuda Y; Nakashima S; Tanida T; Matsuyama J; Nakata K; Tominaga S
Pancreas; 2024 Jan; 53(1):e22-e26. PubMed ID: 38157455
[TBL] [Abstract] [Full Text] [Related]
7. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
8. Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed-effects regression model approach.
Hatanaka T; Kakizaki S; Hiraoka A; Tada T; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Yokohama K; Nishikawa H; Nishimura T; Shimada N; Kawata K; Kosaka H; Naganuma A; Yata Y; Ohama H; Kuroda H; Tanaka K; Tanaka T; Tada F; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Kudo M; Kumada T;
Cancer Med; 2023 Dec; 12(24):21680-21693. PubMed ID: 37987139
[TBL] [Abstract] [Full Text] [Related]
9. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
10.
Tobi M; Weinstein D; Kim M; Hatfield J; Sochacki P; Levi E; An T; Hamre M; Tolia V; Fligiel S; Marepally R; Hallman J; Bapat B; Yuan M; McVicker B; Gallinger S
Curr Oncol; 2023 Aug; 30(9):7950-7963. PubMed ID: 37754493
[TBL] [Abstract] [Full Text] [Related]
11. Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04).
Sugiura T; Toyama H; Fukutomi A; Asakura H; Takeda Y; Yamamoto K; Hirano S; Satoi S; Matsumoto I; Takahashi S; Morinaga S; Yoshida M; Sakuma Y; Iwamoto H; Shimizu Y; Uesaka K
J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1249-1260. PubMed ID: 37746781
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of gemcitabine plus S-1
Zhu Z; Tang H; Ying J; Cheng Y; Wang X; Wang Y; Bai C
Cancer Biol Med; 2023 Aug; 20(10):765-78. PubMed ID: 37646237
[TBL] [Abstract] [Full Text] [Related]
13. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy.
Li J; Du J; Li Y; Meng M; Hang J; Shi H
BMC Gastroenterol; 2023 Aug; 23(1):274. PubMed ID: 37563572
[TBL] [Abstract] [Full Text] [Related]
14. Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract cancer: An Exploratory Analysis of JCOG1113.
Okano N; Morizane C; Okusaka T; Sadachi R; Kataoka T; Kobayashi S; Ikeda M; Ozaka M; Mizutani T; Sugimori K; Todaka A; Shimizu S; Mizuno N; Yamamoto T; Sano K; Tobimatsu K; Katanuma A; Gotoh K; Yamaguchi H; Ishii H; Ohba A; Furuse J; Ueno M;
Oncologist; 2024 Jan; 29(1):e97-e107. PubMed ID: 37531645
[TBL] [Abstract] [Full Text] [Related]
15. Geographical, ethnic, and genetic differences in pancreatic cancer predisposition.
Liew SZH; Ng KW; Ishak NDB; Lee SY; Zhang Z; Chiang J; Ngeow JYY
Chin Clin Oncol; 2023 Jun; 12(3):27. PubMed ID: 37417291
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.
Kitano Y; Inoue Y; Takeda T; Oba A; Ono Y; Sato T; Ito H; Ozaka M; Sasaki T; Sasahira N; Baba H; Takahashi Y
Ann Surg Oncol; 2023 Aug; 30(8):5093-5102. PubMed ID: 37140750
[TBL] [Abstract] [Full Text] [Related]
17. Survival Benefit of Surgical treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.
Chen K; Yu H; Yang J; Bo Z; Jin C; Wu L; Wang Y; Chen G
Curr Oncol; 2023 Feb; 30(3):2642-2652. PubMed ID: 36975414
[TBL] [Abstract] [Full Text] [Related]
18. Adherence to NCCN Genetic Testing Guidelines in pancreatic cancer and Impact on treatment.
Crowley F; Gandhi S; Rudshteyn M; Sehmbhi M; Cohen DJ
Oncologist; 2023 Jun; 28(6):486-493. PubMed ID: 36933202
[TBL] [Abstract] [Full Text] [Related]
19. pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis.
Huang Z; Wang J; Zhang R; He A; Luo S; Wu R; Xiong J; Li M; Jin T; Li E; Wu L; Liao W
Cancer Med; 2023 Apr; 12(8):9926-9936. PubMed ID: 36850060
[TBL] [Abstract] [Full Text] [Related]
20. Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea.
Kim K; Jho HJ; Park SJ; Park B; Choi JY
Epidemiol Health; 2023; 45():e2023021. PubMed ID: 36791793
[TBL] [Abstract] [Full Text] [Related]
[Next]
